RBC Capital Downgrades Adverum Biotech to Sector Perform, PT to $4.

jueves, 15 de mayo de 2025, 12:03 pm ET1 min de lectura
ADVM--
RBC--

RBC Capital Downgrades Adverum Biotech to Sector Perform, PT to $4.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios